Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000440581 | SCV000516577 | pathogenic | not provided | 2015-04-03 | criteria provided, single submitter | clinical testing | The Y284X nonsense variant in the EXT1 gene is predicted to cause loss of normal protein functioneither through protein truncation or nonsense-mediated mRNA decay. The Y284X variant was notobserved in approximately 6,500 individuals of European and African American ancestry in the NHLBIExome Sequencing Project, indicating it is not a common benign variant in these populations. Although thisvariant has not been reported previously to our knowledge, we consider it to be pathogenic. |
Labcorp Genetics |
RCV000800945 | SCV000940690 | pathogenic | Multiple congenital exostosis | 2021-03-29 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals with EXT1-related conditions. ClinVar contains an entry for this variant (Variation ID: 379472). This sequence change creates a premature translational stop signal (p.Tyr284*) in the EXT1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in EXT1 are known to be pathogenic (PMID: 10679937, 11391482, 19810120). This variant is not present in population databases (ExAC no frequency). |